How much funding has Amylin Pharmaceuticals raised?

Amylin Pharmaceuticals has raised $56.0M in total funding, most recently a Venture Round.

When was Amylin Pharmaceuticals founded?

Amylin Pharmaceuticals was founded in 1987.

Where is Amylin Pharmaceuticals headquartered?

Amylin Pharmaceuticals is headquartered in San Diego, California, United States.

What industry is Amylin Pharmaceuticals in?

Amylin Pharmaceuticals operates in Biotech, Healthcare.

How many employees does Amylin Pharmaceuticals have?

Amylin Pharmaceuticals has 1001-5000 employees.

Amylin Pharmaceuticals

Q: Who are Amylin Pharmaceuticals's investors?

Amylin Pharmaceuticals's investors include Bristol Myers Squibb, Sequoia Capital, Sutter Hill, Domain Associates.

IPO

San Diego, United States · Founded 1987 · $56.0M raised

Biotech

Healthcare

Headquarters: San Diego, California
Employees: 1001–5000
Founded: 1987
Business Model: B2B

Website: amylin.com
Total Funding: $56.0M
Last Round: $56.0M Venture RoundJan 1989
Rounds: 1

About

Amylin Pharmaceuticals was a biopharmaceutical company founded in 1987 and headquartered in San Diego, California, with a commercial manufacturing facility in Ohio. The company discovered, developed, and commercialized therapeutics for diabetes and other metabolic diseases, including the GLP-1 therapy exenatide, marketed as Byetta and Bydureon. Amylin was acquired by Bristol-Myers Squibb in 2012 as part of a landmark deal that also involved Eli Lilly.

Summary

Amylin Pharmaceuticals is a Biotech company based in San Diego, United States, founded in 1987. It has raised $56.0M in total across 1 round, most recently a $56.0M Venture Round round in Jan 1989. Investors include Bristol Myers Squibb, Sequoia Capital and Sutter Hill.